Safety and Immunogenicity of a Personalized Synthetic Long Peptide Breast Cancer Vaccine Strategy in Patients With Persistent Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy

Clinical trial NCT02427581 · WITHDRAWN

Trial details

NCT number: NCT02427581
Sponsor: Washington University School of Medicine
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Triple Negative Breast Cancer Triple Negative Breast Neoplasms Triple-Negative Breast Cancer

Start date: 2015-09-29
Primary completion: 2025-12-31
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.